Imidazoline derivatives as alpha-1A adrenoceptor ligands

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S106000, C544S139000, C546S184000, C546S210000, C548S314700, C548S349100, C548S351100, C514S326000, C514S399000

Reexamination Certificate

active

06884801

ABSTRACT:
Compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof are disclosed. Such compounds are useful in the treatment of Alpha-1A mediated diseases or conditions such as urinary incontinence.

REFERENCES:
patent: 3754002 (1973-08-01), Brown et al.
patent: 4506074 (1985-03-01), Huff et al.
patent: 0 887 346 (1998-12-01), None
Hodson et al (2002): J. Med. Chem, vol 45, 2229-2239.*
Saari, Walfred S., J. Med. Chem., (1983), 26, 1769-72.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazoline derivatives as alpha-1A adrenoceptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazoline derivatives as alpha-1A adrenoceptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoline derivatives as alpha-1A adrenoceptor ligands will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3409896

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.